The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The global Therapeutic Drug Monitoring market was valued at US$ 1804.3 million in 2023 and is anticipated to reach US$ 3297.7 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45 percent.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring.
Report Scope
The Therapeutic Drug Monitoring market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Drug Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Drug Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Roche
- Danaher
- Abbott
- Thermo Fisher Scientific
- Siemens Healthineers
- Bio-Rad Laboratories
- bioMerieux
- Bühlmann Laboratories
- Randox Laboratories
- Sekisui Medical
Segment by Type
- Blood Test
- Urine Test
- Saliva Test
Segment by Application
- Hospital Labs
- Independent Clinical Laboratories
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.3 Market by Application
1.3.1 Global Therapeutic Drug Monitoring Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Labs
1.3.3 Independent Clinical Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Drug Monitoring Market Perspective (2019-2030)
2.2 Therapeutic Drug Monitoring Growth Trends by Region
2.2.1 Global Therapeutic Drug Monitoring Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Therapeutic Drug Monitoring Historic Market Size by Region (2019-2024)
2.2.3 Therapeutic Drug Monitoring Forecasted Market Size by Region (2025-2030)
2.3 Therapeutic Drug Monitoring Market Dynamics
2.3.1 Therapeutic Drug Monitoring Industry Trends
2.3.2 Therapeutic Drug Monitoring Market Drivers
2.3.3 Therapeutic Drug Monitoring Market Challenges
2.3.4 Therapeutic Drug Monitoring Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Drug Monitoring Players by Revenue
3.1.1 Global Top Therapeutic Drug Monitoring Players by Revenue (2019-2024)
3.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Players (2019-2024)
3.2 Global Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Drug Monitoring Revenue
3.4 Global Therapeutic Drug Monitoring Market Concentration Ratio
3.4.1 Global Therapeutic Drug Monitoring Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring Revenue in 2023
3.5 Therapeutic Drug Monitoring Key Players Head office and Area Served
3.6 Key Players Therapeutic Drug Monitoring Product Solution and Service
3.7 Date of Enter into Therapeutic Drug Monitoring Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Drug Monitoring Breakdown Data by Type
4.1 Global Therapeutic Drug Monitoring Historic Market Size by Type (2019-2024)
4.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2025-2030)
5 Therapeutic Drug Monitoring Breakdown Data by Application
5.1 Global Therapeutic Drug Monitoring Historic Market Size by Application (2019-2024)
5.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Therapeutic Drug Monitoring Market Size (2019-2030)
6.2 North America Therapeutic Drug Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Therapeutic Drug Monitoring Market Size by Country (2019-2024)
6.4 North America Therapeutic Drug Monitoring Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Drug Monitoring Market Size (2019-2030)
7.2 Europe Therapeutic Drug Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Therapeutic Drug Monitoring Market Size by Country (2019-2024)
7.4 Europe Therapeutic Drug Monitoring Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring Market Size (2019-2030)
8.2 Asia-Pacific Therapeutic Drug Monitoring Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2019-2024)
8.4 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Drug Monitoring Market Size (2019-2030)
9.2 Latin America Therapeutic Drug Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Therapeutic Drug Monitoring Market Size by Country (2019-2024)
9.4 Latin America Therapeutic Drug Monitoring Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring Market Size (2019-2030)
10.2 Middle East & Africa Therapeutic Drug Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2019-2024)
10.4 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Therapeutic Drug Monitoring Introduction
11.1.4 Roche Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Therapeutic Drug Monitoring Introduction
11.2.4 Danaher Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Therapeutic Drug Monitoring Introduction
11.3.4 Abbott Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Introduction
11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Therapeutic Drug Monitoring Introduction
11.5.4 Siemens Healthineers Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.5.5 Siemens Healthineers Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Introduction
11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 bioMerieux
11.7.1 bioMerieux Company Detail
11.7.2 bioMerieux Business Overview
11.7.3 bioMerieux Therapeutic Drug Monitoring Introduction
11.7.4 bioMerieux Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.7.5 bioMerieux Recent Development
11.8 Bühlmann Laboratories
11.8.1 Bühlmann Laboratories Company Detail
11.8.2 Bühlmann Laboratories Business Overview
11.8.3 Bühlmann Laboratories Therapeutic Drug Monitoring Introduction
11.8.4 Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.8.5 Bühlmann Laboratories Recent Development
11.9 Randox Laboratories
11.9.1 Randox Laboratories Company Detail
11.9.2 Randox Laboratories Business Overview
11.9.3 Randox Laboratories Therapeutic Drug Monitoring Introduction
11.9.4 Randox Laboratories Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.9.5 Randox Laboratories Recent Development
11.10 Sekisui Medical
11.10.1 Sekisui Medical Company Detail
11.10.2 Sekisui Medical Business Overview
11.10.3 Sekisui Medical Therapeutic Drug Monitoring Introduction
11.10.4 Sekisui Medical Revenue in Therapeutic Drug Monitoring Business (2019-2024)
11.10.5 Sekisui Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
